In particular, miR‐195 is frequently reported to suppress cell proliferation and metastasis by targeting RPS6KB1 27, BCOX1 28, fibroblast growth factor 2 (FGF2) 29 and PRR11 30, as well as enhance drug resistance in PCa 31, 32. Here, FGF2 is linked to posterior cortical atrophy.